Technology

Cytosorbents

$9.21
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.46 (+5.26%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Cytosorbents and other stocks, options, and ETFs commission-free!

About CTSO

CytoSorbents Corp. engages in the critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio include CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin on April 25, 2002 and is headquartered in Monmouth Junction, NJ. The listed name for CTSO is Cytosorbents Corporation Common Stock.

CEO
Phillip P. Chan
Employees
153
Headquarters
Monmouth Junction, New Jersey
Founded
2002
Market Cap
397.65M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
458.53K
High Today
$9.25
Low Today
$8.65
Open Price
$8.73
Volume
412.81K
52 Week High
$11.74
52 Week Low
$3.60

Collections

CTSO Earnings

-$0.22
-$0.15
-$0.07
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 2, After Hours

You May Also Like

AINC
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure